Mary Gulumian
Mary Gulumian
National Institute for Occupational Health
Dirección de correo verificada de
Citado por
Citado por
Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases
A Shukla, M Gulumian, TK Hei, D Kamp, Q Rahman, BT Mossman
Free Radical Biology and Medicine 34 (9), 1117-1129, 2003
Dissolution and biodurability: Important parameters needed for risk assessment of nanomaterials
W Utembe, K Potgieter, AB Stefaniak, M Gulumian
Particle and fibre toxicology 12, 1-12, 2015
Particle toxicology and health-where are we?
M Riediker, D Zink, W Kreyling, G Oberdörster, A Elder, U Graham, ...
Particle and fibre toxicology 16, 1-33, 2019
Mechanistically identified suitable biomarkers of exposure, effect, and susceptibility for silicosis and coal-worker's pneumoconiosis: a comprehensive review
M Gulumian, PJA Borm, V Vallyathan, V Castranova, K Donaldson, ...
Journal of Toxicology and Environmental Health, Part B 9 (5), 357-395, 2006
Challenges facing sterilization and depyrogenation of nanoparticles: Effects on structural stability and biomedical applications
MA Vetten, CS Yah, T Singh, M Gulumian
Nanomedicine: Nanotechnology, Biology and Medicine 10 (7), 1391-1399, 2014
Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis
V Steenkamp, MC Gouws, M Gulumian, EE Elgorashi, J Van Staden
Journal of Ethnopharmacology 103 (1), 71-75, 2006
The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticles
K Donaldson, PJA Borm, V Castranova, M Gulumian
Particle and fibre toxicology 6, 1-8, 2009
Label-free in vitro toxicity and uptake assessment of citrate stabilised gold nanoparticles in three cell lines
MA Vetten, N Tlotleng, D Tanner Rascher, A Skepu, FK Keter, K Boodhia, ...
Particle and fibre toxicology 10, 1-15, 2013
NanoSolveIT Project: Driving nanoinformatics research to develop innovative and integrated tools for in silico nanosafety assessment
A Afantitis, G Melagraki, P Isigonis, A Tsoumanis, DD Varsou, ...
Computational and Structural Biotechnology Journal 18, 583-602, 2020
Size-dependent clearance of gold nanoparticles from lungs of Sprague–Dawley rats after short-term inhalation exposure
SG Han, JS Lee, K Ahn, YS Kim, JK Kim, JH Lee, JH Shin, KS Jeon, ...
Archives of toxicology 89, 1083-1094, 2015
Risk assessment of benzene, toluene, ethyl benzene, and xylene concentrations from the combustion of coal in a controlled laboratory environment
MD Masekameni, R Moolla, M Gulumian, D Brouwer
International journal of environmental research and public health 16 (1), 95, 2019
Hazards identified and the need for health risk assessment in the South African mining industry
W Utembe, EM Faustman, P Matatiele, M Gulumian
Human & experimental toxicology 34 (12), 1212-1221, 2015
From the Cover: An Investigation of the Genotoxicity and Interference of Gold Nanoparticles in Commonly Used In Vitro Mutagenicity and Genotoxicity Assays
JM George, M Magogotya, MA Vetten, AV Buys, M Gulumian
Toxicological Sciences 156 (1), 149-166, 2017
Toward rigorous materials production: new approach methodologies have extensive potential to improve current safety assessment practices
P Nymark, M Bakker, S Dekkers, R Franken, W Fransman, ...
Small 16 (6), 1904749, 2020
Antioxidant and genotoxic properties of South African herbal extracts
V Steenkamp, H Grimmer, M Semano, M Gulumian
Mutation Research/Genetic Toxicology and Environmental Mutagenesis 581 (1-2 …, 2005
Cytotoxicity, intracellular localization and exocytosis of citrate capped and PEG functionalized gold nanoparticles in human hepatocyte and kidney cells
N Tlotleng, MA Vetten, FK Keter, A Skepu, R Tshikhudo, M Gulumian
Cell biology and toxicology 32, 305-321, 2016
Transcriptomics in toxicogenomics, part I: experimental design, technologies, publicly available data, and regulatory aspects
PAS Kinaret, A Serra, A Federico, P Kohonen, P Nymark, I Liampa, MK Ha, ...
Nanomaterials 10 (4), 750, 2020
The role of oxidative stress in diseases caused by mineral dusts and fibres: current status and future of prophylaxis and treatment
M Gulumian
Stress Adaptation, Prophylaxis and Treatment, 69-77, 1999
Transcriptomics in toxicogenomics, part III: data modelling for risk assessment
A Serra, M Fratello, L Cattelani, I Liampa, G Melagraki, P Kohonen, ...
Nanomaterials 10 (4), 708, 2020
Introducing a new standardized nanomaterial environmental toxicity screening testing procedure, ISO/TS 20787: aquatic toxicity assessment of manufactured nanomaterials in …
SA Johari, K Rasmussen, M Gulumian, M Ghazi-Khansari, N Tetarazako, ...
Toxicology Mechanisms and Methods 29 (2), 95-109, 2019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20